All Stories

  1. Copper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase
  2. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model
  3. Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase
  4. Metal-detection based techniques and their applications in metallobiology
  5. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex
  6. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
  7. Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
  8. Metalloproteomics
  9. Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stress
  10. Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms
  11. Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
  12. A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases
  13. Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection
  14. Metallomics and metalloproteomics
  15. Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity
  16. Metal Complexes as Resistance Breakers or Metalloantibiotics for Combating Antimicrobial Resistance
  17. Computed Tomography of Cartilage: An Exploration of Novel Cationic Bismuth Contrast Agent
  18. Binding of ruthenium and osmium at non‑iron sites of transferrin accounts for their iron-independent cellular uptake
  19. An ensemble 3D deep-learning model to predict protein metal-binding site
  20. Metalloproteomics for Biomedical Research: Methodology and Applications
  21. Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
  22. Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation
  23. A hydroxide lock for metallo-β-lactamases
  24. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
  25. Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
  26. Metal-based strategies for the fight against COVID-19
  27. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL
  28. Eradication of Porphyromonas gingivalis Persisters Through Colloidal Bismuth Subcitrate Synergistically Combined With Metronidazole
  29. Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  30. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  31. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
  32. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
  33. A. Sigel, E. Freisinger & R. K. O. Sigel (Eds.), M. E. Sosa Torres & P. M. H. Kroneck (volume Eds.): Transition Metals and Sulfur – A Strong Relationship for Life
  34. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
  35. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
  36. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
  37. Bismuth—The Magic Element
  38. Atomic differentiation of silver binding preference in protein targets:Escherichia colimalate dehydrogenase as a paradigm
  39. Bismuth drugs as antimicrobial agents
  40. Predicting disease-associated mutation of metal-binding sites in proteins using a deep learning approach
  41. Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli
  42. Recognition of Proteins by Metal Chelation-Based Fluorescent Probes in Cells
  43. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
  44. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
  45. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells
  46. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping
  47. A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
  48. Green Fluorescent Probe for Imaging His6-Tagged Proteins Inside Living Cells
  49. MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers
  50. Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli
  51. Bismuth: Environmental Pollution and Health Effects
  52. Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
  53. S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells
  54. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
  55. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
  56. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum
  57. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
  58. Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
  59. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism inHelicobacter pylorion bismuth treatment
  60. Tracking iron-associated proteomes in pathogens by a fluorescence approach
  61. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival
  62. A Ni-NTA-based red fluorescence probe for protein labelling in live cells
  63. Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags
  64. Identification of catabolite control protein A fromStaphylococcus aureusas a target of silver ions
  65. Integration of fluorescence imaging with proteomics enables visualization and identification of metallo-proteomes in living cells
  66. Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
  67. Exploration into the nickel ‘microcosmos’ in prokaryotes
  68. UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori
  69. Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
  70. Rapid labeling of intracellular His-tagged proteins in living cells
  71. Loss of APD1 in Yeast Confers Hydroxyurea Sensitivity Suppressed by Yap1p Transcription Factor
  72. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs
  73. “Anion clamp” allows flexible protein to impose coordination geometry on metal ions
  74. On-line coupling of continuous-flow gel electrophoresis with inductively coupled plasma-mass spectrometry to quantitatively evaluate intracellular metal binding properties of metallochaperones HpHypA and HpHspA in E. coli cells
  75. Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography
  76. Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET
  77. Antimony and Bismuth
  78. Structure of RPA32 bound to the N‐terminus of SMARCAL1 redefines the binding interface between RPA32 and its interacting proteins
  79. Urease inactivation by an unusual GroES chaperonin
  80. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth
  81. In-cell NMR: an emerging approach for monitoring metal-related events in living cells
  82. Size-tunable fabrication of multifunctional Bi2O3 porous nanospheres for photocatalysis, bacteria inactivation and template-synthesis
  83. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori
  84. BiOX (X=Cl, Br, I) nanostructures: Mannitol-mediated microwave synthesis, visible light photocatalytic performance, and Cr(VI) removal capacity
  85. Identification of Metal‐Associated Proteins in Cells by Using Continuous‐Flow Gel Electrophoresis and Inductively Coupled Plasma Mass Spectrometry
  86. ChemInform Abstract: Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment.
  87. Tunable BiOCl hierarchical nanostructures for high-efficient photocatalysis under visible light irradiation
  88. Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1
  89. Binding of oxo-Cu2 clusters to ferric ion-binding protein A from Neisseria gonorrhoeae: a structural insight
  90. Histidine-rich proteins in prokaryotes: metal homeostasis and environmental habitat-related occurrence
  91. Interaction of SlyD with HypB of Helicobacter pylori facilitates nickel trafficking
  92. Structure-oriented bioinformatic approach exploring histidine-rich clusters in proteins
  93. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
  94. Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment
  95. Metallomics in environmental and health related research: Current status and perspectives
  96. Facile Microwave Synthesis of 3D Flowerlike BiOBr Nanostructures and Their Excellent CrVI Removal Capacity
  97. Recent advances in bioinorganic chemistry of bismuth
  98. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
  99. Covalently linking the Escherichia coli global anaerobic regulator FNR in tandem allows it to function as an oxygen stable dimer
  100. Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA
  101. Large-scale synthesis of bismuth hollow nanospheres for highly efficient Cr(vi) removal
  102. Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
  103. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
  104. Probing of bismuth antiulcer drug targets in H. pylori by laser ablation-inductively coupled plasma mass spectrometry
  105. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation
  106. Microwave synthesis of BiPO4 nanostructures and their morphology-dependent photocatalytic performances
  107. Assembly of Preactivation Complex for Urease Maturation inHelicobacter pylori
  108. Histidine-rich protein Hpn from Helicobacter pylori forms amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells
  109. Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
  110. Metal‐Binding Properties of an Hpn‐Like Histidine‐Rich Protein
  111. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  112. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  113. NMR Studies of Metalloproteins
  114. Biological Chemistry of Arsenic, Antimony and Bismuth
  115. Biological Chemistry of Antimony and Bismuth
  116. Metalloproteomics of Arsenic, Antimony and Bismuth Based Drugs
  117. Polymeric architectures of bismuth citrate based on dimeric building blocks
  118. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization
  119. Iron-containing lipoprotein SiaA in SiaABC, the primary heme transporter of Streptococcus pyogenes
  120. Nuclear-based Metallomics in Metal-based Drugs
  121. Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties
  122. A new capillary electrophoresis buffer for determining organic and inorganic anions in electroplating bath with surfactant additives
  123. A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
  124. A biomimetic zinc activated ion channel
  125. Metallomics: An integrated science for metals in biology and medicine
  126. Metallomics: An integrated biometal science
  127. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
  128. Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex
  129. Structure of a Nickel Chaperone, HypA, from Helicobacter pylori Reveals Two Distinct Metal Binding Sites
  130. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2
  131. The structural and biological significance of the EAAEAE insert in the α-domain of human neuronal growth inhibitory factor
  132. Crystal Structure and Metal Binding Properties of the Lipoprotein MtsA, Responsible for Iron Transport in Streptococcus pyogenes
  133. Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes
  134. Important roles of the conserved linker-KKS in human neuronal growth inhibitory factor
  135. Identification and characterization of metallodrug binding proteins by (metallo)proteomics
  136. Editorial and Advisory Board profiles
  137. Identification of Proteins Related to Nickel Homeostasis in Helicobater pylori by Immobilized Metal Affinity Chromatography and Two-Dimensional Gel Electrophoresis
  138. Study on structure–property–reactivity–function relationship of human neuronal growth inhibitory factor (hGIF)
  139. Binding of Ni2+ to a histidine- and glutamine-rich protein, Hpn-like
  140. Structure, topology and assembly of a 32-mer peptide corresponding to the loop 3 and transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  141. A Histidine-rich and Cysteine-rich Metal-binding Domain at the C Terminus of Heat Shock Protein A from Helicobacter pylori
  142. Lipoprotein MtsA of MtsABC in Streptococcus pyogenes primarily binds ferrous ion with bicarbonate as a synergistic anion
  143. Double-strand DNA cleavage by copper complexes of 2,2′-dipyridyl with guanidinium/ammonium pendants
  144. The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein
  145. Biocoordination chemistry of bismuth: Recent advances
  146. Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor
  147. Bismuth Complexes Inhibit the SARS Coronavirus
  148. Bismuth Complexes Inhibit the SARS Coronavirus
  149. Bioinorganic Chemistry of Bismuth and Antimony: Target Sites of Metallodrugs
  150. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
  151. Solution structures, dynamics, and lipid‐binding of the sterile α‐motif domain of the deleted in liver cancer 2
  152. Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation
  153. Metallodrugs
  154. An Effective Metallohydrolase Model with a Supramolecular Environment: Structures, Properties, and Activities
  155. Bioinorganic Chemistry of Bismuth and Antimony:  Target Sites of Metallodrugs
  156. Silver nanoparticles: partial oxidation and antibacterial activities
  157. Synthesis, Structure, and Activity of Supramolecular Mimics for the Active Site and Arg141 Residue of Copper, Zinc−Superoxide Dismutase
  158. Encapsulation of platinum anticancer drugs by apoferritin
  159. Inhibition of SARS coronavirus helicase by bismuth complexes
  160. Cleavage of double-strand DNA by zinc complexes of dicationic 2,2′-dipyridyl derivatives
  161. Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
  162. Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugs
  163. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3
  164. Thermodynamic and Kinetic Aspects of Metal Binding to the Histidine-rich Protein, Hpn
  165. The role of Thr5 in human neuron growth inhibitory factor
  166. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
  167. Solution structure and dynamics of human metallothionein‐3 (MT‐3)
  168. HFIP‐induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
  169. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate
  170. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni 2+ storage in Helicobacter pylori
  171. Complexation of antimony (SbV) with guanosine 5′-monophosphate and guanosine 5′-diphospho-d-mannose: Formation of both mono- and bis-adducts
  172. An Insight of S-Nitrosylation of Human GIF
  173. The Stepwise Process of Chromium-Induced DNA Breakage:  Characterization by Electrochemistry, Atomic Force Microscopy, and DNA Electrophoresis
  174. Transferrin-Mediated Gold Nanoparticle Cellular Uptake
  175. 51 Sb Antimony in Medicine
  176. NMR structures and orientation of the fourth transmembrane domain of the rat divalent metal transporter (DMT1) with G185D mutation in SDS micelles
  177. Structure, Assembly, and Topology of the G185R Mutant of the Fourth Transmembrane Domain of Divalent Metal Transporter
  178. Controlled synthesis of high crystalline bismuth sulfide nanorods: using bismuth citrate as a precursor
  179. In Vitro Inhibition of Human Immunodeficiency Virus Type‐1 (HIV‐1) Reverse Transcriptase by Gold(III) Porphyrins
  180. Dynamic and Kinetic Aspects of Metallodrugs by NMR
  181. The low pKa value of iron‐binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin
  182. Inhibition of alcohol dehydrogenase by bismuth☆
  183. Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane‐mimetic environments
  184. Bismuth in Medicine
  185. DNA hydrolysis promoted by di- and multi-nuclear metal complexes
  186. The effect of the EAAEAE insert on the property of human metallothionein-3
  187. Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)
  188. Recognition of antimony and bismuth by peptides and proteins: insight into the mechanism of action
  189. Three dimensional structures and topology of the transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  190. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
  191. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter
  192. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma
  193. Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details...
  194. An oscillating C22? unit inside a copper rectangleElectronic supplementary information (ESI) available: NMR spectra and computational details. See http://www.rsc.org/suppdata/cc/b3/b301842c/
  195. Helicases as antiviral drug targets
  196. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activationElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b2/b210240d/
  197. Complexation of ytterbium to human transferrin and its uptake by K562 cells
  198. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
  199. Stereo- and Enantioselective Alkene Epoxidations: A Comparative Study of D4- and D2-Symmetric Homochiral trans-Dioxoruthenium(VI) Porphyrins
  200. The role of the transferrin–transferrin-receptor system in drug delivery and targeting
  201. Interactions of Bismuth with Human Lactoferrin and Recognition of the BiIII−Lactoferrin Complex by Intestinal Cells
  202. Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
  203. Intracellular Sb-trypanothione
  204. Complexation of Antimony(III) by Trypanothione
  205. Interaction of antimony tartrate with the tripeptide glutathione
  206. TiIV Uptake and Release by Human Serum Transferrin and Recognition of TiIV-Transferrin by Cancer Cells:  Understanding the Mechanism of Action of the Anticancer Drug Titanocene Dichloride
  207. Stereoselective Formation of Seven-Coordinate Titanium(IV) Monomer and Dimer Complexes of Ethylenebis(o-hydroxyphenyl)glycine
  208. ChemInform Abstract: Transferrin as a Metal Ion Mediator
  209. Interactions of Bismuth Complexes with Metallothionein(II)
  210. Transferrin as a Metal Ion Mediator
  211. Coordination chemistry of metals in medicine: target sites for bismuth
  212. Bismuth Antiulcer Complexes
  213. N-lobe versus C-lobe complexation of bismuth by human transferrin
  214. Coordination of Zn2+ (and Cd2+) by Prokaryotic Metallothionein
  215. The First Specific TiIV-Protein Complex: Potential Relevance to Anticancer Activity of Titanocenes
  216. [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions
  217. New approach to the solution chemistry of bismuth citrate antiulcer complexes
  218. The Biological and Medicinal Chemistry of Bismuth
  219. Determination of Bismuth in Serum Urine by Direct Injection Nebulization Inductively Coupled Plasma Mass Spectrometry
  220. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
  221. Rationalization of the Strength of Metal Binding to Human Serum Transferrin
  222. Molecular assemblies of diazafluorenone Schiff-base amphiphiles. III.13C NMR investigations of reversed micelles in deuteriochloroform
  223. Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly)
  224. Solid-state carbon-13 nuclear magnetic resonance investigations of bismuth citrate complexes and crystal structure of Na2[Bi2(cit)2]·7H2O
  225. 1H NMR Studies of the Imidazole Complex of Cytochrome c: Resonance Assignment and Structural Characterization of the Heme Cavity
  226. Ranitidine bismuth(III) citrate
  227. NMR Investigation of the Aggregation Behavior of Diazafluorenone Schiff Base Amphiphile in CDCL3Solution
  228. Assignments of Nonexchangeable Proton Resonances and the Solution Structures of d–TGGGT
  229. Syntheses and Characterization of Coenzyme B12 Analogues Containing 2′-Deoxynucleosede
  230. Two Dimensional1HNMR Studies on 2′5′-Dideoxyadenosylcobalamin